Atlas Trials

N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis

Clinical trial NCT03069300 · UNKNOWN

Trial details

NCT number
NCT03069300
Sponsor
Imperial College London
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Alcoholic HepatitisInfection
Start date
2015-10-01
Primary completion
2022-04-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.